InvestorsHub Logo
Followers 13
Posts 109
Boards Moderated 0
Alias Born 11/16/2019

Re: The_Q post# 39722

Friday, 07/02/2021 5:20:34 PM

Friday, July 02, 2021 5:20:34 PM

Post# of 43788
Q - Here is a P3 study that passed its primary endpoint with only 62 participants.

https://clinicaltrials.gov/ct2/show/NCT03566238?term=pfic&draw=2&rank=4

Here are the results of that P3 study.

https://seekingalpha.com/news/3612011-albireos-odevixibat-successful-in-late-stage-study-shares-up-74-percent
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News